Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.

Journal: Cell

Published: 2020-04-15

DOI: 10.1016/j.cell.2020.03.039

Affiliations: 14

Authors: 19

Go to article
Institutions Share
UCSF Diabetes Center, United States of America (USA) 0.25
UCSF Department of Microbiology and Immunology, United States of America (USA) 0.24
Innovative Genomics Institute (IGI), United States of America (USA) 0.23
UCSF Medical Scientist Training Program (MSTP), United States of America (USA) 0.06
UCSF Biomedical Sciences Program (BMS), United States of America (USA) 0.06
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.03
UCSF Sean N. Parker Autoimmune Research Laboratory, United States of America (USA) 0.03
Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA) 0.03
UCSF Department of Medicine (DOM), United States of America (USA) 0.02
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.02
UCSF Institute for Human Genetics, United States of America (USA) 0.01
UCSF Division of Rheumatology, United States of America (USA) 0.01
UCSF Bakar Computational Health Sciences Institute (BCHSI), United States of America (USA) 0.01
UCSF Department of Epidemiology and Biostatistics, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER